We are live on ! Find out more
BJCM

Blue Jay Capital Management Portfolio holdings

AUM $147M
1-Year Est. Return 64.18%
This Fund
S&P 500
This Quarter Est. Return
-8.1%
1 Year Est. Return
+64.18%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$156M
AUM Growth
-$140M
Cap. Flow
-$135M
Cap. Flow %
-86.57%
Top 10 Hldgs %
75.5%
Holding
31
New
8
Increased
4
Reduced
4
Closed
15

Top Buys

Rank Stock Value
1
IONS icon
Ionis Pharmaceuticals
IONS
+$12.9M
2
MJN
Mead Johnson Nutrition Company
MJN
+$12.4M
3
IART icon
Integra LifeSciences
IART
+$11.2M
4
ABMD
Abiomed Inc
ABMD
+$10.4M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$6.61M

Top Sells

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$20.2M
2
EW icon
Edwards Lifesciences
EW
+$19.9M
3
BIIB icon
Biogen
BIIB
+$17.8M
4
ENDP
Endo International plc
ENDP
+$15.6M
5
BXLT
BAXALTA INC COM STK (DE)
BXLT
+$15M

Sector Composition

Rank Sector Weight
1 Healthcare 84.17%
2 Consumer Staples 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ENDP
26
DELISTED
Endo International plc
ENDP
– –
-255,080
Closed -$15.6M
CERN
27
DELISTED
Cerner Corp
CERN
– –
-216,339
Closed -$13M
WMGI
28
DELISTED
Wright Medical Group Inc
WMGI
– –
-450,000
Closed -$10.9M
IPXL
29
DELISTED
Impax Laboratories, Inc.
IPXL
– –
-295,000
Closed -$12.6M
CPHD
30
DELISTED
Cepheid Inc
CPHD
– –
-290,000
Closed -$10.6M
BXLT
31
DELISTED
BAXALTA INC COM STK (DE)
BXLT
– –
-385,000
Closed -$15M
1
2

Similar funds

BCM
Breithorn Capital Management New York $141M AUM 41.82% 1-Year Est. Return
RJA
Robshaw & Julian Associates Williamsville, New York $140M AUM 13.69% 1-Year Est. Return
RP
Ridgegate Proprietary Sydney, Australia $154M AUM 25.47% 1-Year Est. Return
ACPVT
ABS Capital Partners V Trust Baltimore, Maryland $123M AUM
SFA
Staton Financial Advisors Charlotte, North Carolina $118M AUM 11.07% 1-Year Est. Return
KL
Kinsight LLC Birmingham, Alabama $176M AUM 17.21% 1-Year Est. Return
KFS
Kissinger Financial Services Hunt Valley, Maryland $100M AUM 6.22% 1-Year Est. Return
FHC
First Houston Capital Houston, Texas $100M AUM 23.45% 1-Year Est. Return

Blue Jay Capital Management's Q1 2016 Portfolio in Review

As of Q1 2016, Blue Jay Capital Management held 31 positions worth $156M, down 47% from $297M the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Blue Jay Capital Management withdrew a net $135M in Q1 2016, closing 15 positions and reducing 4 holdings. Its most notable exit was Intuitive Surgical, an estimated $20.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, up from 83% a quarter earlier, followed by Consumer Staples.

Against the trend, Blue Jay Capital Management opened a new position in Ionis Pharmaceuticals worth $12.9M.

  • Blue Jay Capital Management's largest Q1 2016 buy was Ionis Pharmaceuticals: 318,490 shares worth $12.9M.
  • Blue Jay Capital Management added most to Neurocrine Biosciences in Q1 2016, an estimated $6.21M increase.
  • Blue Jay Capital Management's biggest Q1 2016 reduction was Shire pic, cutting an estimated $7.85M.
  • Blue Jay Capital Management fully exited Intuitive Surgical in Q1 2016, selling an estimated $20.2M.
  • Blue Jay Capital Management's ten largest holdings make up 75% of its $156M portfolio in Q1 2016.
  • Blue Jay Capital Management opened 8 new positions and closed 15 in Q1 2016.
  • Blue Jay Capital Management's portfolio value fell 47% quarter-over-quarter to $156M.

Based on Blue Jay Capital Management's 13F filing for Q1 2016, filed 13 May 2016.